Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Stopped Study halted prematurely, prior to enrollment of first participant due to protracted logistical and subsequent funding matters.

Conditions

• Lymphoma, Non-Hodgkin

Interventions

• DRUG: Standard anti-emetics in conjunction with R-CHOP

Sponsor

Australasian Leukaemia and Lymphoma Group

Collaborators

• [object Object]